SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $619 | +15.1% | 30,071 | +113.0% | 0.01% | -25.0% |
| Q4 2022 | $538 | -100.0% | 14,116 | -79.6% | 0.01% | -77.1% |
| Q3 2022 | $2,711,000 | -41.3% | 69,233 | -51.6% | 0.04% | -38.6% |
| Q2 2022 | $4,617,000 | -18.4% | 142,955 | -16.4% | 0.06% | -20.8% |
| Q1 2022 | $5,657,000 | +144.9% | 170,910 | +227.8% | 0.07% | +132.3% |
| Q3 2021 | $2,310,000 | +33.0% | 52,134 | +70.5% | 0.03% | +63.2% |
| Q2 2021 | $1,737,000 | +460.3% | 30,580 | +637.4% | 0.02% | +280.0% |
| Q1 2021 | $310,000 | +49.8% | 4,147 | +73.2% | 0.01% | +150.0% |
| Q4 2020 | $207,000 | -85.5% | 2,395 | -89.7% | 0.00% | -92.9% |
| Q3 2020 | $1,425,000 | -9.3% | 23,310 | -38.3% | 0.03% | -31.7% |
| Q2 2020 | $1,571,000 | +152.2% | 37,786 | +1010.7% | 0.04% | +64.0% |
| Q2 2019 | $623,000 | – | 3,402 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |